Alexander Nowak
Stock Analyst at Craig-Hallum
(4.07)
# 464
Out of 4,784 analysts
48
Total ratings
50%
Success rate
14.23%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $12.49 | +76.14% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $143.94 | +9.07% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $9.03 | +88.26% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $34.89 | +63.37% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $10.24 | +163.67% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $17.96 | -16.48% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.82 | +109.42% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $0.70 | +42.86% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.82 | +163.93% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $19.28 | +159.34% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.62 | +1,184.11% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $43.66 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.86 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.80 | +511.11% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $58.73 | +87.30% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.68 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.11 | +9,546.30% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.47 | +411.88% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $12.49
Upside: +76.14%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $143.94
Upside: +9.07%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $9.03
Upside: +88.26%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $34.89
Upside: +63.37%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $10.24
Upside: +163.67%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $17.96
Upside: -16.48%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.82
Upside: +109.42%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $0.70
Upside: +42.86%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.82
Upside: +163.93%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $19.28
Upside: +159.34%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.62
Upside: +1,184.11%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $43.66
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.86
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.80
Upside: +511.11%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $58.73
Upside: +87.30%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.68
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.11
Upside: +9,546.30%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $5.47
Upside: +411.88%